Work

Patient-Reported Outcomes from the Randomized Phase 3 CROWN Study of First-Line Lorlatinib versus Crizotinib in ALK plus NSCLC

Year: 2021

Type: article

Source: Journal of Thoracic Oncology

Authors: Julien Mazières, Laura Iadeluca, Alice T. Shaw, Brad Solomon, Todd M. Bauer, Filippo de Marinis, Enriqueta Felip, Yoshinari Goto, D Kim, Tony Mok, Arlene Reisman, Holger Thurm, Anna Polli, G Liu

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3184639746

FWCI:

Cites:

Cited by:

Related to: